Pharma IQ Talking Heads - Global Pharmaceutical Contract Manufacturing Roundtable 2012
Contract Manufacturing in Pharmaceuticals continues to increase…
Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny. As a result there has been an increase in the need for a reduction in the size and cost of internal manufacturing and sourcing of cheaper products from external parties.
Recent reports indicate that the global pharmaceutical contract manufacturing market will be worth US$40.7 billion by 2015 - Are you effectively leveraging external supply and managing the risks involved to make the most of your outsourcing options?
As the pharmaceutical industry relies on faster drug development and cost containment to maintain growth, there has never been a more important time to develop strategic CMO alliances to facilitate entry into emerging markets, reduce costs and increase product revenue. But with so many CMOs to choose from, how can you guarantee that you have the right partner to provide the services you require with minimal risk and maximum efficiency?
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags: contract manufacturing | pharma contract manufacturing | CMO | global contract manufacturing | contract manufacturing market | pharmaceutical contract manufacturing market | CMOs | contract research organisation | contract research organization
To receive the white paper on this topic please submit your information in the form below.
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.
-
Global Pharmaceutical and Bio Contract Manufacturing (GPCM and GBCM)
Chelsea Football Club, London, UK
June 26- 27, 2012 -
Outsourcing: Challenging the Project Management System at Your Organisation
July 19, 2011
Register Now -
2nd Annual Pharma Regulatory Affairs Asia
Amara Singapore Hotel, Singapore
April 25- 26, 2012 -
5th Annual Bio/Pharmaceutical Cold Chain Management Asia
Singapore Expo
May 28- 30, 2012
-
CMO-Client Relationships: Extremes and Standardisation
Ian Anderson Director, External Networks, M&S Business Unit Norgine, spoke to Pharma IQ about the... Read more
Ian Anderson
-
The True Cost of Not Having Brand Protection
With the performance of new and existing IPs potentially being the difference between success and failure in... Read more
Pharma IQ







Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!